Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Fumihiko Takizawa"'
Autor:
Shun Moriguchi, Yuri Mukoyama, Fumihiko Takizawa, Atsushi Ogawa, Tetsushi Ogawa, Junko Ito, Yukishige Yanagawa, Chinatsu Komiyama, Rieko Niitsu, Tsuyoshi Isojima
Publikováno v:
Endocrine Journal, Vol 71, Iss 7, Pp 713-719 (2024)
Cardiovascular disease is one of the most important complications in girls and women with Turner syndrome (TS). Although the latest international guideline provides useful suggestions for the management of cardiovascular diseases in TS, some unknown
Externí odkaz:
https://doaj.org/article/cb58e2361d014ca788231b1d2cc76869
Publikováno v:
Clinical and experimental nephrology. 25(6)
Turner syndrome (TS) is a chromosomal disorder with various complications, including congenital anomaly of the kidney and urinary tract (CAKUT). However, its renal function remains poorly known. Therefore, this study aimed to evaluate renal function
Autor:
Fumihiko Takizawa, Farouc A. Jaffer, Thomas Michel, Yasutomi Higashikuni, Andre Manika, Masataka Sata, Yoshihiro Ogawa, Hirotaka Watada, Yasutomi Kamei, Kevin Croce, Kyu Tae Kang, Laura E. Benjamin, Naoki Sawada, Chase W. Kessinger, Zolt Arany, Joyce Bischoff, Rica Tanaka, Aihua Jiang, Yevgenia Tesmenitsky, Juliano L. Sartoretto, Adeel Safdar, Hermann Kalwa
Publikováno v:
Cell Metabolism. 19(2):246-258
SummaryEndothelial dysfunction is a central hallmark of diabetes. The transcriptional coactivator PGC-1α is a powerful regulator of metabolism, but its role in endothelial cells remains poorly understood. We show here that endothelial PGC-1α expres
Autor:
Fumihiko Takizawa, Makoto Ono, Satoshi Kusuda, Masahiko Kawai, Makoto Oshiro, Tetsuo Hattori, Reiko Horikawa, Kazutoshi Cho
Publikováno v:
Pediatrics International. 54:177-181
Background: Although the administration of levothyroxine sodium (LT4) to premature infants had been considered safe, several cases of late-onset circulatory collapse (LCC) following the administration of LT4 in very-low-birth-weight (VLBW) infants ha
Autor:
Toshikazu Onishi, Fumihiko Takizawa, Makoto Ono, Kei Takasawa, Kentrao Miyai, Yohei Matsubara, Shuki Mizutani, Kenichi Kashimada
Publikováno v:
Endocrine Journal. 59:1001-1006
An initial high-dose treatment of glucocorticoid has been proposed to prevent chronic androgen excess, improving the final height prognosis of 21-hydroxylase deficiency (21-OHD) patients. In Japan, it is recommended to use an extremely high-dose of h
Autor:
Junichi Shimizu, Shuki Mizutani, Fumihiko Takizawa, Makoto Ono, Keisuke Enomoto, Kentaro Miyai, Kenichi Kashimada, Goro Asada
Publikováno v:
Pediatrics International. 52:e154-e157
Autor:
Kei Takasawa, Toshikazu Onishi, Kentaro Miyai, Shuki Mizutani, Yohei Matsubara, Kenichi Kashimada, Fumihiko Takizawa, Makoto Ono
Publikováno v:
Endocrine journal. 60(2)
Substitution therapy of glucocorticoid is a major part of the treatment for 21-OHD (21-hydroxylase deficiency). However, the therapy causes two major adverse effects, impairment of linear growth and obesity, so that collecting precise growth data is
Autor:
Masahiko, Kawai, Satoshi, Kusuda, Kazutoshi, Cho, Reiko, Horikawa, Fumihiko, Takizawa, Makoto, Ono, Tetsuo, Hattori, Makoto, Oshiro
Publikováno v:
Pediatrics international : official journal of the Japan Pediatric Society. 54(2)
Although the administration of levothyroxine sodium (LT4) to premature infants had been considered safe, several cases of late-onset circulatory collapse (LCC) following the administration of LT4 in very-low-birth-weight (VLBW) infants have been repo
Autor:
Fumihiko, Takizawa, Kenichi, Kashimada, Keisuke, Enomoto, Kentaro, Miyai, Makoto, Ono, Goro, Asada, Junichi, Shimizu, Shuki, Mizutani
Publikováno v:
Pediatrics international : official journal of the Japan Pediatric Society. 52(3)
Publikováno v:
Pediatric nephrology (Berlin, Germany). 23(9)